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Background: PstA is a cyclic di-AMP receptor and PII-like signal transduction protein.
Results: Apo-PstA and complex crystal structures reveal a novel cyclic di-AMP-binding mode and induced conformational
changes.
Conclusion: PstA has a similar fold but distinct signal transduction properties from classic PII proteins, which function in
nitrogen metabolism.
Significance: Identification of common features allows for rational prediction of cyclic di-AMP-binding sites.
Signaling nucleotides are integral parts of signal transduction
systems allowing bacteria to cope with and rapidly respond to
changes in the environment. The Staphylococcus aureusPII-like
signal transduction protein PstA was recently identified as a
cyclic diadenylate monophosphate (c-di-AMP)-binding pro-
tein.Here, we present the crystal structures of the apo- and c-di-
AMP-bound PstA protein, which is trimeric in solution as well
as in the crystals. The structures combined with detailed bioin-
formatics analysis revealed that the protein belongs to a new
family of proteins with a similar core fold but with distinct fea-
tures to classical PII proteins,whichusually function innitrogen
metabolism pathways in bacteria. The complex structure
revealed three identical c-di-AMP-binding sites per trimer with
each binding site at a monomer-monomer interface. Although
distinctly different from other cyclic-di-nucleotide-binding
sites, as the half-binding sites are not symmetrical, the complex
structure also highlighted common features for c-di-AMP-
binding sites. A comparison between the apo and complex
structures revealed a series of conformational changes that
result in the ordering of two anti-parallel !-strands that pro-
trude from each monomer and allowed us to propose a mech-
anism on how the PstA protein functions as a signaling trans-
duction protein.
Bacteria have evolved intricate signal transduction systems
to detect and rapidly respond to changes in the environment.
These systems include two-component systems, which nor-
mally consist of a membrane-embedded histidine kinase that
senses an environmental stimulus and transduces this signal to
an intracellular response regulator that coordinates an appro-
priate transcriptional response (1). In addition, various intra-
cellular signal transduction proteins or domains within larger
proteins can directly bind intracellular metabolites and adjust
their activities or that of binding partner effector proteins very
rapidly without the need of de novo protein synthesis. Other
molecules, which have emerged as key components in signal
transduction systems, are signaling nucleotides (2). In particu-
lar, cyclic dinucleotides have gained increased attention during
recent years partly due to the discovery of novel nucleotides
such as cyclic diadenylate monophosphate (c-di-AMP)4 and
cyclic adenylate guanylate monophosphate (c-AMP-GMP)
(3–6).
c-di-AMP is a widely distributed signaling nucleotide among
the Gram-positive Firmicutes and Actinobacteria (7, 8). The
stimuli leading to the production of c-di-AMP are currently not
well understood.However, recent genome-wide protein-nucle-
otide interaction studies have led to the identification of several
c-di-AMP-specific target proteins, providing the first clues
toward pathways that are controlled by c-di-AMP. Currently
known c-di-AMP-binding proteins include the cytoplasmic
gating component KtrA/C of the Ktr potassium transport sys-
tem, the histidine kinase KdpD, part of a two-component sys-
tem that controls the expression of the Kdp potassium trans-
port system, and CpaA, a predicted cation-proton antiporter,
all identified in Staphylococcus aureus (9). Another c-di-AMP-
binding protein is DarR, a transcription factor discovered in
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Mycobacterium smegmatis and suggested to be involved in the
regulation of the expression of genes involved in fatty acid bio-
synthesis (10). Recently, c-di-AMP has also been described as
an allosteric inhibitor of the Listeria monocytogenes pyruvate
carboxylase, which is an essential metabolic enzyme that con-
verts pyruvate to oxaloacetate (11). In the samework, four other
hypothetical proteins were identified as c-di-AMP-binding
proteins (11). One of these proteins of unknown function has
also been previously identified as a c-di-AMP-binding protein
in S. aureus and namedPstA, based on a bioinformatics analysis
and its annotation as a PII-like signal transduction protein (9).
The S. aureus PstA protein is the focus of this study. Using a
structural, mutagenesis, and biochemical approach, we aimed
to provide a better understanding on its function. Specifically,
we aimed to determine whether this protein has all necessary
features to serve as bona fide signal transduction proteins and
how the interaction with c-di-AMP could lead to a signaling
output. Very limited information is currently available on PII-
like signal proteins such as PstA; however, much is known
about prototypical PII proteins. These classical PII proteins are
highly conserved and are some of the most widely distributed
signal transduction proteins in nature, and they play a key role
in nitrogen metabolism in bacteria and archaea (12–14). PII
proteins function as trimers and through protein-protein inter-
actions control the activity of a number of different proteins
ranging from enzymes, transcription factors to membrane
transporters. The ability of PII proteins to interact with their
effector proteins is regulated through post-translational modi-
fications as well as the binding of ligands, including ADP, ATP,
Mg2!, and 2-oxoglutarate (2-OG), where 2-OG acts as a signal
of the nitrogen availability in cell (15).
Based on sequence and operon structure, classical PII pro-
teins have been grouped into the GlnB/K, the NifI, and an
uncharacterized PII-New group (16). PII-like signal transduc-
tion proteins such as PstA share too little sequence similarity
with these classical PII proteins and have not been included in
previous bioinformatics analyses. The best characterized PII
proteins belong to the GlnB/K group, which includes the
closely related GlnB and GlnK proteins. Crystal structures of
several GlnB andGlnK proteins with and without bound ligand
have been reported (17–22). These studies revealed that PII
proteins form homotrimers and have a highly conserved three-
dimensional structure. Each monomer has a compact core
made up of two !-helices and four "-strands, which are con-
nected by so called T- and B-loops (13, 15). PII proteins interact
through their T-loop with effector proteins, and in the absence
of this protein-protein interaction, the T-loop is very flexible
and is often unresolved in crystal structures (13, 15). The
smaller B-loop contains a Walker A motif typical for an ATP-
binding site (21). Under low nitrogen conditions, when the cel-
lular 2-OG pool is high, PII proteins cooperatively bind 2-OG,
ATP, and a Mg2! ion. Two highly conserved residues, Gln-39
and Lys-58, which are located at the beginning and end of the
T-loop, respectively, play a key role in ligand binding.When the
2-OG pool drops under high nitrogen conditions, PII proteins
switch to the ADP-bound state with residues Gln-39 and
Lys-58 now forming a salt bridge instead of interacting with the
ligands (23–25). This results in the T-loop adopting two differ-
ent conformations depending on the cellular 2-OG concentra-
tion, allowing PII proteins to interact or disengage with their
specific effector proteins.
The binding of 2-OG is therefore a key aspect of the sensory
capacity of classical PII signal transduction proteins. However,
an exception has been reported for a member of the GlnB/K
group, which does not appear to bind 2-OG, and hence might
sense and respond to different signals (25). Also, the effector
binding properties of the PII-New group are currently not
known. Finally, the recent identification of the PII-like signal
transduction proteins in S. aureus andL.monocytogenes as c-di-
AMP-binding proteins indicates that the processes controlled
by PII-like proteins and the regulatorymolecules these proteins
respond to are evenmore complex than previously anticipated.
To elucidate the signal transduction capacity of the S. aureus
PstA protein as well as provide information on the mode of
c-di-AMP binding and its functional consequence, we per-
formed a structural, biochemical, and mutagenesis analysis.
Our analyses revealed that PstA proteins are clearly distinct
from classical and previously characterized PII proteins and
provide a rationale for the c-di-AMP binding in PstA versus the
ATP,Mg2!, and 2-OG binding in PII proteins. The co-complex
crystal structure between c-di-AMP and the S. aureus PstA pro-
tein not only revealed the nucleotide-protein interactions but a
comparison with the apo-PstA structure allowed us to suggest
amechanism for the signal transductionproperties of this protein.
EXPERIMENTAL PROCEDURES
Strain and Plasmid Constructions—Bacterial strains and
primers used in this study are listed in Tables 1 and 2, respec-
tively. Escherichia coli strains were grown in Luria Bertani (LB)
medium. When appropriate, cultures were supplemented with
antibiotics as indicated in Table 1. The construction of plasmid
pET28b-His-pstA, for the expression and purification of N-ter-
minally His-tagged PstA (His-PstASA) protein from S. aureus,
has been described in a previous study (9). pET28b-His-pstA
was used as a template in PCRs for the construction of the
plasmids used for the expression of the different His-PstASA
variants with alanine substitutions or amino acid deletions.
Specifically, for construction of plasmid pET28b-His-pstA-
(T28A), primer pairs ANG1591/ANG1875 and ANG1876/
ANG1592 were used in the first round of PCR. The resulting
products were gel-purified and fused using primer pair
ANG1591/ANG1592 in a second round of PCR. The final prod-
uct was digestedwith enzymesNdeI and EcoRI and ligatedwith
plasmid pET28b that has been cut with the same enzymes. Plasmids
pET28b-His-pstA(GGFL-AAAA), pET28b-His-pstA(N41A),
pET28b-His-pstA(T43A), pET28b-His-pstA(R67A), andpET28b-
His-pstA("d71–87), were constructed in a similar manner
replacing primers ANG1875/ANG1876 with primers ANG1877/
ANG1878,ANG1879/ANG1880,ANG1881/ANG1882,ANG1883/
ANG1884, andANG1886/ANG1887, respectively. For construction
of plasmid pET28b-His-pstA(K2A), primer pair ANG1931/
ANG1592 was used. The resulting products were digested and
ligated with cut pET28b plasmid as described above. All plas-
mids were initially recovered in E. coli strain XL-1 Blue, and
sequences of inserts were confirmed by fluorescent automated
sequencing (GATC Biotech). For protein expression and
c-di-AMP-PstA Co-complex
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purification, the plasmids were introduced in E. coli strain
BL21(DE3) (Table 1).
Plasmid pET28b-disABT-His was produced for the expres-
sion and purification of the C-terminally His-tagged c-di-AMP
cyclase DisA from Bacillus thuringiensis (DisABT-His) using a
strategy similar to that described by Zheng et al. (26). To this
end, the disA gene was amplified fromB. thuringiensisBMB171
(27) chromosomal DNA by PCR using primer pair ANG1711/
1712. The resulting product was cut with restriction enzymes
NcoI and XhoI and ligated with plasmid pET28b, which has
been cut with the same enzymes. The resulting plasmid,
pET28b-disABT-His, was initially obtained inE. coli strainXL-1
Blue yielding strainANG3043. For protein expression, the plas-
mid was introduced into strain BL21(DE3) yielding strain
ANG3048.
Protein Expression and Purification—E. coli BL21(DE3) strains
(Table 1) were used for the expression and purification of the
N-terminallyHis-taggedPstA (His-PstASA) protein and the dif-
ferent His-PstA variants. 1-liter cultures of the different strains
were grown at 37 °C to anA600 of 0.5 to 0.7, and protein expres-
sion was induced with 0.5 mM isopropyl 1-thio-"-D-galactopy-
ranoside (IPTG) and cultures were incubated overnight at 16 or
18 °C. Protein purifications by Ni-NTA affinity chromatogra-
phy were performed as previously described with the exception
that 10 mM imidazole was included in the lysis buffer (28). Pro-
teins were further purified by size exclusion chromatography
using a 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5% glycerol
buffer system. Protein containing fractions were pooled and
concentrated to around 3 mg/ml using 10-kDa cutoff filtration
devices. For crystallization studies, a 20 mM Tris-HCl, pH 7.5,
buffer was used for the size exclusion chromatography and the
protein was concentrated to #10 mg/ml. Protein concentra-
tions were determined using the BCA Protein assay kit from
Pierce. The purity of the purified proteins was assessed onCoo-
TABLE 1
Bacterial strains used in this study
Strain Relevant features Ref.
E. coli strains
XL1 Blue Cloning strain, TetR--ANG127 Stratagene
BL21(DE3) E. coli strain used for protein expression--ANG191 Novagen
ANG1824 pET28b in XL1 Blue; KanR Novagen
ANG1867 pET28b in BL21 (DE3); KanR Novagen
ANG2702 pET28b-His-pstA in XL1 Blue; KanR 9
ANG2711 pET28b-His-pstA in BL21 (DE3); KanR 9
ANG3043 pET28b-disABT-His in XL1 Blue; KanR This study
ANG3048 pET28b-disABT-His in BL21 (DE3); KanR This study
ANG3352 pET28b-His-pstA (K2A) in XL1 Blue; KanR This study
ANG3278 pET28b-His-pstA (D12A) in XL1 Blue; KanR This study
ANG3280 pET28b-His-pstA (T28A) in XL1 Blue; KanR This study
ANG3279 pET28b-His-pstA (GGFL-AAAA) in XL1 Blue; KanR This study
ANG3282 pET28b-His-pstA (N41A) in XL1 Blue; KanR This study
ANG3283 pET28b-His-pstA (T43A) in XL1 Blue; KanR This study
ANG3285 pET28b-His-pstA (R67A) in XL1 Blue; KanR This study
ANG3286 pET28b-His-pstA ("71–87) in XL1 Blue; KanR This study
ANG3353 pET28b-His-pstA (K2A) in BL21 (DE3); KanR This study
ANG3292 pET28b-His-pstA (D12A) in BL21 (DE3); KanR This study
ANG3293 pET28b-His-pstA (T28A) in BL21 (DE3); KanR This study
ANG3296 pET28b-His-pstA (GGFL-AAAA) in BL21 (DE3); KanR This study
ANG3294 pET28b-His-pstA (N41A) in BL21 (DE3); KanR This study
ANG3295 pET28b-His-pstA (T43A) in BL21 (DE3); KanR This study
ANG3297 pET28b-His-pstA (R67A) in BL21 (DE3); KanR This study
ANG3298 pET28b-His-pstA ("71–87) in BL21 (DE3); KanR This study
Other strains
BMB171 B. thuringiensis BMB171– NG3001 27
TABLE 2
Primers used in this study
Restriction sites are underlined.
Number Name Sequence
ANG1591 F-NdeI-PstA GGGCATATGAAAATGATTATAGCGATCGTACAAG
ANG1592 R-EcoRI-PstA GGGGAATTCTTAAAATTGATGGAATGCATCAAC
ANG1711 5-NcoI-DisA-Bt CATGCCATGGAAGAAAATAAGCAACGTGTCAAAAG
ANG1712 3-XhoI-DisA-Bt CCGCTCGAGATTGTGTCTACTCATATAGAGATGCTCTTG
ANG1872 H6.pstA (D12A)-F GGAATTCCATATGAAAATGATTATAGCGATCGTACAAGATCAAGCTAGTCAGGAACTTGC
ANG1875 H6.pstA (T28A)-R GTTGTTGCCAATTTTGCTGCTCTAAAGTTATTTTTAAC
ANG1876 H6.pstA (T28A)-F CAGCAAAATTGGCAACAACAGGTGG
ANG1877 H6.pstA (GGFL-AAAA)-R TTGCAGCCGCAGCTGTTGTTGCCAATTTTGTTG
ANG1878 H6.pstA (GGFL-AAAA)-F CAGCTGCGGCTGCAAGAGCGGGTAATACAACATTC
ANG1879 H6.pstA (N41A)-R GCACCCGCTCTTAAAAACCCAC
ANG1880 H6.pstA (N41A)-F TTTAAGAGCGGGTGCTACAACATTCTTATGTGGTGTC
ANG1881 H6.pstA (T43A)-R TGCTGTATTACCCGCTCTTAAAAACC
ANG1882 H6.pstA (T43A)-F GCGGGTAATACAGCATTCTTATGTGGTGTCAATG
ANG1883 H6.pstA (R67A)-R TCTGCATTACCACACGTTTGATTAATC
ANG1884 H6.pstA (R67A)-F GTGTGGTAATGCAGAACAGTTGGTTTCACC
ANG1886 H6.pstA ("71–87)-R CAACTGTTCTCTATTACCACACGTTTG
ANG1887 H6.pstA ("71–87)-F AATAGAGAACAGTTGCCAGTTGAAGTTGAAGTTGG
ANG1931 H6.pstA (K2A)-F GGAATTCCATATGGCAATGATTATAGCGATCGTACAAGATCAAG
c-di-AMP-PstA Co-complex
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massie stained gels following separation of the indicated
amount of protein on 15% (w/v) SDS-polyacrylamide gels.
Protein Crystallization and Structure Determination—For
crystallization, sitting-drop trials were set up by robot (Mos-
quito, TTP Labtech) in 96-wellplates using 1440 different com-
mercial conditions (Molecular Dimension: MemStart, Mem-
Sys, PACT premier, JCSG-plus, MemGold, ProPlex, PGA
Screen; Hampton Research: Crystal Screen, PEG/Ion Screen 1
and 2, Natrix, Index, SaltRx; Rigaku: Wizard Classic 1, 2 and 3;
Jena Bioscience: JBScreen Cryo HTS) with 50 #l solution per
well and a 200 nl drop size (100 nl reservoir and 100 nl protein
solution, at 20 °C). The crystals of His-PstASA appeared in 2 to
3 days at 20 °C under four different conditions: 100mM sodium
citrate, pH 4.6, 0.2 M KCl, 37% pentaerythritol propoxylate
(condition 1), 100 mM sodium acetate pH 4.6, 30% MPD (con-
dition 2), 200 mMNamalonate pH 4.6 and 20% PEG3350 (con-
dition 3), 200 mM succinic acid, pH 6.8 (condition 4). The best
crystals were obtained in condition 3. Data collection was
performed at 100K at the SOLEIL synchrotron, beamline
PROXIMA 1 from a single crystal grown in condition 3. The
His-PstASA crystals belonged to space group P321with unit cell
parameters a$ 56.75Å, b$ 56.75Å, c$ 66.17Å, !$ "$ 90°,
$$ 120°.
Data were indexed in XDS (29), scaled in SCALA (30) and
Rfree was generated randomly in UNIQUE (31). Molecular
replacementwas performed in PHENIX (32) using an ensemble
of each monomer of the structure of Pediococcus pentosaceus
ATCC 25745 protein PEPE_1480 (PDB code 3M05), a PstA
homolog, as a search model. Two datasets were collected from
the same crystal and merged together to obtain high multiplic-
ity for sulfur phasing (total rotation %$ 360°). However anom-
alous signal extended only to 4.5Å hampering direct experi-
mental phasing. Nevertheless, anomalousmapswere generated
in SFALLS (31) and superposed on the MR solution to guide
model building starting from the sulfur-containing amino
acids, followed by the building of aromatic amino acids in
COOT (33). Ten cycles of rigid body refinement (10.0–6.0Å)
were followed by 10 cycles of restrained body refinement
(49.18–2.8Å) in REFMAC (34) leading to Rfactor$ 0.25 Rfree$
0.29. TLS group analysis was performed using the TLSMD-
server (35) and performed in REFMAC. Model building was
reiterated in COOT and structure validation was performed in
MOLPROBITY (36). Final statistics for data collection and
model refinement are presented in Table 3. The structure-
based sequence alignment was generated in PyMOL and ana-
lyzed with JALVIEW (37). Structural homology searches were
performed using the DALI server (38) and amino acid conser-
vation was mapped onto the crystal structure using ConSurf
(39).
For co-crystallization studies, His-PstASA at a concentration
of 10 mg/ml was incubated in 20 mM Tris-HCl, pH 7.5, 10 mM
MgCl2 buffer containing 4 mM c-di-AMP (InvivoGen) for 30
min on ice and subsequent crystallization trials were performed
in condition 3, analogous to the apo-protein. Data collection
was performed from a single crystal at 100K at SOLEIL syn-
chrotron, beam line PROXIMA2. The crystals belonged to
space group I121 with unit cell parameters: a $ 64.21Å, b $
65.65Å, c$ 85.16Å, !$ 90°, "$ 95.98°, $$ 90°. The structure
was solved by molecular replacement using the apo-structure
as a model in PHASER (40). Model building, refinement and
validation were performed as described for the apo-structure.
The final Rfactor and Rfree were 0.19 and 0.23, respectively.
Superposition of the apo and complex structures was per-
formed with SUPERPOSE (31). The structures were deposit in
the protein data bank under PDB codes 4D3G (apo PstA) and
4D3H (c-di-AMP/PstA complex).
Preparation of E. coli Whole Cell Lysates—For the prepara-
tion of whole cell lysates, E. coli BL21(DE3) strains containing
the empty pET28b vector, pET28b-His-pstA or derivatives
thereof for the expression of the different His-PstASA variants,
were grown overnight at 30 °C in LB medium. The next morn-
ing, the protein expressed was induced with 1 mM isopropyl
1-thio-"-D-galactopyranoside, and the cultures were incubated
for a further 6 h at 30 °C. Bacteria from 1 ml of culture were
collected by centrifugation and suspended to an A600 of 40 in
binding buffer (40 mM Tris, pH 7.5, 100 mM NaCl, 10 mM
MgCl2), containing 2 mM PMSF, 20 #g/ml DNase, and 0.5
mg/ml lysozyme. Cells were lysed by three freeze and thaw
cycles and subsequently used in binding assays or stored at
%20 °C.
Synthesis of 32P-Labeled c-di-AMP—32P-Labeled c-di-AMP
was synthesized from [!-32P]ATP (PerkinElmer Life Sciences)
by incubating 55.5 nM [!-32P]ATPwith 2#MpurifiedB. thuren-
gensisDisABT-His protein in 40mMTris, pH 7.5, 100mMNaCl,
10 mM MgCl2 binding buffer at 45 °C overnight. The sample
was subsequently incubated for 10 min at 95 °C, and the Dis-
ABT-His protein was removed by centrifugation at 17,000 & g
for 5 min; the supernatant was transferred to a new tube and
stored at%20 °C. The conversion of [!-32P]ATP to 32P-labeled
TABLE 3
Crystallographic data and refinement statistics
PstA apo PstA" c-di-AMP
Beamline PROXIMA1 PROXIMA2
Space group P321 I121
Cell parameters
a, b, c (Å), 56.75, 56.75, 66.17, 64.21, 65.65, 85.16
!, ", $ (o) 90.00, 90.00, 120.00 90.00, 95.98, 90.00
Wavelength (Å) 1.82 0.98
Resolution (Å) 49.12-3.00 (3.16-3.00) 42.35-2.00 (2.05-2.00)
Rmerge 0.109 (0.556) 0.083 (0.446)
Rpim (all I! and I%) 0.018 (0.090) 0.057 (0.293)
'I(/S.D. 'I( 27.2 (7.9) 9.6 (2.9)
Completeness (%) 100.0 (100.0) 99.2 (99.8)
Redundancy 38.2 (38.7) 3.5 (3.5)
Wilson B factor (Å2) 82.7 22.1
No. of reflections 102,187 (14500) 82,553 (6093)
No. of unique 2672 (375) 23,649 (1739)
CC (1/2) 0.999 (0.987) 0.996 (0.862)
Rfactor 0.246 (0.385) 0.188 (0.243)
Rfree 0.293 (0.485) 0.232 (0.261)
No. of atoms 605 2780
Protein 605 2474
Waters 174
c-di-AMP 132
Average B-factors (Å2)
Protein 47.1 23.6
Water 32.2
c-di-AMP 16.6
Root mean square
deviations
Bond lengths (Å) 0.011 0.014
Bond angles (°) 1.28 1.82
Ramachandran most
favored ( %)
97 100
Ramachandran allowed 3 0
PDB code 4D3G 4D3H
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c-di-AMPwas estimated to be 87–96%, as assessed by TLC and
densitometry analysis, which was performed as described pre-
viously (9).
Differential Radial Capillary Action of Ligand Assay
(DRaCALA)—c-di-AMP binding to His-PstASA or its variants
was performed with DRaCALAs, the principle of which is
described in Roelofs et al. (41) and was adapted by Corrigan et
al. (9) to study c-di-AMP protein interactions. Briefly, E. coli
whole cell lysates or 10 #M solutions of purified protein (for
standard assays) in binding buffer were mixed with#1 nM 32P-
labeled c-di-AMP and incubated at room temperature for 5
min. Then, 2.5#l of these reactions were spotted onto nitrocel-
lulose membranes (Hybond-ECL, GE Healthcare) and air-
dried, and radioactivity signals were detected and quantified as
described previously (9, 41). For Kdmeasurement, 2-fold serial
dilutions of purified His-PstASA or the different variants were
prepared in binding buffer (40 mM Tris, pH 7.5, 100 mM NaCl,
10 mM MgCl2) at a starting concentration of 300 #M and sub-
sequently mixed with #1 nM 32P-labeled c-di-AMP. The frac-
tions of ligand bound and Kd values were calculated as
described previously (41). To determine koff values, a 10 #M
solution of purified His-PstASA protein in binding buffer was
mixed with 1 nM 32P-labeled c-di-AMP and incubated at room
temperature for 5 min. Then, 2.5 #l of these reactions were
spotted onto nitrocellulosemembranes and set as time 0. After-
ward, cold c-di-AMP at a final concentration of 300 #M was
added to the remaining sample, and after incubation for 10, 20,
30, 40, 50, 60, 90, 120, and 180 s, 2.5 #l of these reaction were
FIGURE 1.Multiple sequence alignment of PstASA homologs andPstASA oligomerization state.A, 911 PstASA homologswere identified using a PSI-BLAST
search and aligned with Cluster Omega. Exemplars for a few closely related family members (SAUSA300_0460, S. aureus subsp. aureus USA300_FPR3757
(CA-MRSA); BSU00290, B. subtilis subsp. subtilis 168; Lmo2692, L. monocytogenes EGD-e) and a few distantly related members (Dtur_0788, Dictyoglomus
turgidum; Sthe_0949, Sphaerobacter thermophiles; Trd_0200, Thermomicrobium roseum) are shown along with the logo motif produced for all PstASA
homologs. The full alignment can be obtained from the authors. Highly conserved amino acids are indicated with black asterisks. B, SEC-MALs analysis of
purified His-PstASA. A 100 #M solution of purified His6-PstASA protein was analyzed by SEC-MALs and the molar mass and differential refractive index plotted
versus the elution volume from a Superdex-200 10/300 column. The purified His6-PstASA protein (calculated mass of 13.9 kDa) eluted as a 43.9-kDa complex
indicating that the protein forms a trimer in solution. Of note, the first peak is likely aggregated protein, which eluted in the void volume of the column. Inset
on the left shows a Coomassie-stained gel with 1 #g of purified protein and molecular mass marker proteins with sizes shown in kDa.
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spotted onto a nitrocellulose membrane. The fraction of ligand
bound and koff values were calculated as described previously
(41).
Multiangle Laser Light Scattering (SEC-MALs) Analysis—
Purified His-PstASA protein was adjusted to a concentration of
100 #M in 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 5%
glycerol buffer. One hundred microliters of this solution was
subjected to a size exclusion chromatography step using a
Superdex 10/300 column, which was coupled to a multiangle
laser light scattering detector (Wyatt Technology Corp.). The
data were processed with the ASTRA 5.3.4 software and fitted
according to the Zimmmodel for static light scattering. Exper-
iments were repeated twice with two different protein prepara-
tions, and a representative graph is shown.
Bioinformatics Analysis—The PstASA protein sequence
(SAUSA300_0460) was used as query sequence in a PSI-BLAST
search using default settings to identify homologs in the NCBI
nonredundant protein sequence database. Four iterations of
the search were performed at which point only the number of
classical PII proteins increased. This yielded 911 sequences
with amaximum expect (e) values below 3e-04 and aminimum
sequence coverage and sequence identity of 60 and 30%, respec-
tively. These sequences were exported and used in JALVIEW
(37) and a multisequence alignment generated after 10 itera-
tions and a conserved logo-sequence with Cluster Omega (42).
RESULTS
Bioinformatics Analysis of PstA Proteins—PstA, a PII-like sig-
nal transduction protein of unknown function,was identified as
a c-di-AMP receptor protein in both S. aureus and L. monocy-
togenes (9, 11). To gain insight into the phylogenetic distribu-
tion of PstA-type proteins and define common and unique
features compared with classical PII proteins, a detailed bioin-
formatics analysis was carried out. A PSI-BLAST search was
performed using the PstA protein SAUSA300_0460 from S.
aureusUSA300_FPR3757 (from here on referred to as PstASA)
as query sequence. This yielded 911 sequences with maximum
expect (e) values below 3e-04 and a minimum sequence cover-
age and sequence identity of 60 and 30%, respectively. The
majority of the retrieved sequences was annotated as hypothet-
ical proteins, although several were annotated as nitrogen reg-
ulatory PII-related proteins. Next, a multiple sequence align-
ment was performed with the 911 PstA-like sequences with
ClusterOmega and 10 iterations, until the alignment was stable
and a consensus logo motif was generated (Fig. 1A). This anal-
ysis revealed that amino acids Lys-2, Asp-12, and Arg-67 (using
PstASA protein amino acid numbers) were highly conserved
and present in more than 95% of the PstA sequences (Fig. 1A).
In addition, highly conserved amino acidmotifs were identified
between residues Thr-28 and Thr-43 with the consensus
sequence of TKLXXXGGFLXXGNTT and a highly conserved
FIGURE2.Crystal structureof apo-PstASA.A, schematic representationof the crystal structures of a PstASAmonomerwith!-helices and"-strands numbered,
and unstructured T)- and B)-loops schematically indicated; B, overlay between PstASA (orange) and the P. pentosacues ATCC 25745 protein PEPE_1480 (PDB
code 3M05) (gray); andC, PstASA trimerwith the individualmonomers shown in different colors.D, electrostatic surface potential representation (blue,positive
potential; red, negative potential) of the PstASA trimer shown on the left in the same orientation as in schematic representation in C and on the right rotated
by!180o around the y axis.
c-di-AMP-PstA Co-complex
JANUARY 30, 2015•VOLUME 290•NUMBER 5 JOURNAL OF BIOLOGICAL CHEMISTRY 2893
 at Imperial College London on October 26, 2015
http://www.jbc.org/
Downloaded from 
94GGA96 amino acid stretch toward the C-terminal end of the
protein (Fig. 1A). A segment of #30 amino acids between the
conserved residues Arg-67 and Gly-94 showed the highest
sequence variation; as discussed later, this region is likely
involved in effector protein binding (Fig. 1A).
Apo Structure of PstASA—To further characterize the PstASA
protein, we pursued the determination of its structure. The
N-terminally His-tagged PstASA protein (His-PstASA) was
expressed and purified from E. coli strain BL21(DE3) (Fig. 1B).
TheHis-PstASA protein has a calculatedmass of 13.9 kDa; how-
ever, SEC-MALs analysis revealed that the protein forms a
43.9 * 0.84-kDa complex in solution (Fig. 1B) suggesting that
PstASA is trimeric in solution, similar to classical PII proteins.
The crystal structure of the S. aureus PstA proteins was deter-
mined at 3.0 Å resolution by molecular replacement using the
structure of the Pediococcus pentosaceus ATCC 25745 protein
PEPE_1480 (PDB code 3M05) as a model (Fig. 2,A and B). This
protein, which is also of unknown function, shares 48%
sequence identity with PstASA. Although the PstASA protein
crystallized as amonomer in the asymmetric unit, upon inspec-
tion of the crystal packing it became clear that the protein forms
trimers within the crystal lattice consistent with a trimeric state in
solution (Fig. 2,C andD). ThePstASAmonomer includes a core of
four"-strands and two!-helices connected by two highly flexible
loops (Fig. 2, A and B). The amino acids from 34 to 40, which
following the nomenclature for PII proteins will be referred to as
T)-loop residues, and residues 68 to92,whichwill be referred to as
B)-loop residues, were not visible in the electron density maps
indicating that these residues are disordered (Fig. 2A). The main
inter-monomer contacts in the PstASA trimer are provided by the
interaction of "4, from one monomer with the C terminus of the
neighboring monomer, through a network of hydrogen bonds
(Fig. 2C). Inspection of the surface potential of the trimer high-
lighteda large, accessible, andpositively chargedarea at themono-
mer-monomer interface (Fig. 2D), which, similar to the recently
reported structure of the L. monocytogenes pyruvate carboxylase
enzyme in complexwith c-di-AMP (11), could serve as a potential
nucleotide-binding site.
Structural Comparison of PstA and Classical PII Proteins—
Structural similarity searches using the DALI server identified
PII proteins as close structural homologs to the PstASA protein.
Structure-based alignments (Fig. 3A) and the superposition of
PstASA with members of the PII proteins family revealed a high
degree of structural similaritywithin the core fold of the protein
FIGURE 3. Structural comparison of PstA and classical PII proteins. A, structure-based alignment of PstASA, P. pentosacues ATCC 25745 protein PEPE_1480
(PDB code 3M05), E. coli PII proteins GlnK (PDB code 1GNK), E. coli GlnB (PDB code 2PII), and Archaeoglobus fulgidus PII protein AF_1750 (PDB code 3TA2). The
secondary structures for PstASA and 3TA2 are shown above and below the alignment, respectively, with T/T)- and B/B)-loops indicated with dashed lines. Also,
the highly conserved PII protein residues Gln-39 and Lys-58 at the base of the T-loop as well as the highly conserved TGXXGDGKImotif within the B-loop of PII
proteins are indicated with asterisks. B, overlay of the PstASA monomer structure (orange) in schematic representation with the monomer structure of the A.
fulgidus PII protein AF_1750 in the ATP, Mg2! (green dot), and bound to the 2-OG ligand (PDB code 3TA2); C, overlay with the monomer structure of the A.
fulgidus PII protein AF_1750 in the ADP ligand-bound form (PDB code 3TA1) (24). T- and B-loops as well as highly conserved amino acids Gln-39 and Lys-58
(shown in stick representation) as well as ATP, 2-OG, and ADP ligands are labeled in B and C. D, overlay of the surface potential representation of the PstASA
protein with the A. fulgidus PII protein AF_1750 and bound ligand in schematic representation.
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but with considerable variation in the size and sequence of the
loops (Fig. 3). Specifically, the large T-loop in PII proteins,
which is involved in protein-protein interactions is replaced
with a shorter T)-loop in PstA (Fig. 3A). Furthermore, the
highly conserved residues Gln-39 and Lys-58 found in PII pro-
teins at the beginning and the end of the T-loop, respectively,
are absent in PstA-like proteins (Fig. 3). These two residues play
a key role in the signal transduction function of PII proteins (15,
23, 24). They are involved in the binding of 2-OG/Mg2!/ATP/,
at a high intracellular 2-OG concentration, although at a low
2-OG concentration when the PII protein is in the ADP-bound
state, these two residues form a salt bridge, leading to a drastic
change in the conformation of the T-loop (Fig. 3, B and C) (15,
23, 24). Furthermore, the B-loop of PII proteins is replaced in
PstA by a larger loop that lacks the highly conserved B-loop
motif TGXXGDGKI, which is essential for ATP binding in PII
proteins (Fig. 3A). In summary, the comparative sequence and
structural analyses suggest that PstASA belongs to a new family
of proteins with a similar core fold but with distinct features to
PII proteins. The biological function of PstA-like proteins is
currently not known. However, the absence of key residues
required for ATP, Mg2!, and 2-OG binding and hence the
function of classical PII proteins suggest that PstA proteins
have a cellular function distinct from classical PII proteins.
Interaction of PstASA with c-di-AMP—Previous work on
PstASA has shown that the protein can bind c-di-AMP (9). This
binding is specific as other nucleotides, including ATP, cyclic
adenylate monophosphate (cAMP), or cyclic diguanylate
monophosphate (c-di-GMP), could not compete for the bind-
ing, even when present in large excess over c-di-AMP (9). The
intracellular c-di-AMP concentration in S. aureus is in the low
micromolar range (9). To assess whether the interaction
between c-di-AMP and PstASA is physiological, theKd value for
this interaction was determined by the differential radial capil-
lary action of ligand assay (DRaCALA) (41) using purified His-
PstASA protein and 32P-labeled c-di-AMP. Using this method,
an interaction with a Kd of 0.37* 0.03 #M was measured (Fig.
4A). This interaction is in a physiologically relevant range and
comparable with previously reported Kd values for other c-di-
AMP target proteins of S. aureus and L. monocytogenes, which
were in the range of 0.1 to 8 #M (9–11). The koff value for
c-di-AMP and His-PstASA in the presence of 300 #M cold c-di-
AMP was determined as 0.076 * 0.005 s%1 (Fig. 4B), which
corresponds to a half-life of 9.1 s, indicating a rapid equilibrium
of bound and free protein.
PstASA Structure in Complex with c-di-AMP—To gain
molecular insights into the nucleotide protein interactions, the
c-di-AMP!PstASA complex structure was pursued. To this end,
theHis-PstASA proteinwas incubatedwith 4mMc-di-AMPand
subsequently co-crystallized. The protein crystallized as a
trimer in the asymmetric unit, and the crystal structure of the
protein!ligand complex was solved at 2.0Å resolution bymolec-
ular replacement using the apo structure as a model (Fig. 5A).
The c-di-AMP bound at the monomer-monomer interface
with three molecules bound per trimer (Fig. 5B). Superposition
of the ligand!complex structure with the apo structure revealed
no major changes within the core of the protein and a root
mean square deviation (r.m.s.d.) for the C! atoms of 0.9 Å for
the trimer. The main differences between the unbound and
bound structures was in the T)-loop, which was disordered
in the apo structure but became structured in the c-di-
AMP!PstASA complex, thereby providing many stabilizing
interactions with the ligand, particularly through Phe-36 (see
detailed description below). In addition, the large B)-loop
(amino acids 68–92), which was unresolved in the apo struc-
ture, was more ordered in the complex, forming two anti-par-
allel "-strands (Fig. 5A). In the c-di-AMP!PstASA complex
structure, a salt bridge is formed between the highly conserved
amino acids Asp-12 in !-helix 1 and Arg-67 at the beginning of
the B)-loop (Fig. 5,A and C). In the apo structure no salt bridge
is observed, as only density for the C" is present for Arg-67 (Fig.
5C).
Clear density for the c-di-AMP ligand was visible at each
monomer-monomer interface within the PstASA trimer (Fig.
5D).Thec-di-AMP-bindingmodeatthethreemonomer-mono-
mer interfaces is equivalent, and therefore only the interaction
at the monomer A-monomer B interface will be discussed. The
c-di-AMP-binding site is overall positively charged due to res-
idues Asn-24, Asn-41, andGln-108, with the latter two residues
being in hydrogen bonding distance with the ligand (Fig. 5E).
Both phosphate groups of the ligand form oxy-anion holes; one
such anion-stabilizing hydrogen-bonding pocket is formed by
the interaction of the PO4 group 1 with two water molecules
and the backbone amides of Phe-36 and Leu-37 (monomer B),
FIGURE 4. Binding characteristics between c-di-AMP and PstASA. A,
binding curve and Kd determination for c-di-AMP and purified His-PstASA.
DRaCALAswereperformedwith 32P-labeledc-di-AMPandpurifiedHis-PstASA
at a starting protein concentration of 300 #M, and fraction-bound and Kd
values were determined from the curve as described previously (41). The
average values from three independent experiments are plotted with stan-
dard deviations. B,dissociation curve and koff determination for c-di-AMPand
purified His-PstASA. A 10#M solution of purified His-PstA was incubated with
32P-labeled c-di-AMP. At time 0, 300 #M cold c-di-AMP was added, and the
displacement of 32P-labeled c-di-AMP was measured at 10-, 20-, 30-, 40-, 50-,
60-, 90-, 120-, and 180-s timepoints. Fraction-bound valueswere plotted, and
the koff value was determined as described previously (41). The average val-
ues from three independent experiments are plotted with standard
deviations.
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whereas another is formed by the PO4 group 2 through hydro-
gen bonding with Gln-108 and two water molecules (Fig. 6).
The adenine ringA! is held in place by a face-to-face& stacking
interaction with Phe-36 (monomer B) and a &-cation interac-
tion with Arg-26 (monomer A), whereas the adenine ring A"
forms a face-to-edge stacking interaction with Phe-99, and
three hydrogen bonds with the amide and carbonyl group of
Gly-47 (monomer A) and the side chain of Thr-28 (monomer
A). Asn-41 forms a hydrogen bond with the ribose ring, and
additional hydrogen bonds are formed between surrounding
waters, which are conserved across three monomers, and the
oxygen and nitrogen groups of the ribose and adenine rings,
respectively (Fig. 6). It is notable that although each monomer
provides approximately half a ligand-binding site, the interac-
tions with the ligand are very different in each half-binding site.
Mutagenesis Analysis Confirms Essential Function of Con-
served c-di-AMP-interacting Residues—The sequence analysis
(Fig. 1A) and the c-di-AM!PstASA complex structure (Figs. 5
and 6) highlighted several conserved residues involved in c-di-
AMP binding. To confirm the physiological relevance of the
c-di-AMP-binding site observed in the complex structure, a
mutagenesis analysis was performed. Specifically, the con-
served amino acids Thr-28 and Asn-41 mutated to alanines as
well as the GGFL amino acids (residues 34–37) that form the
small T)-loop of PstA proteins were simultaneously mutated to
alanines. Variants with these mutations were expected to be
compromised in c-di-AMP binding as these residues make
direct contact with the ligand (Fig. 6). As control, other highly
conserved residues Lys-2 and Thr-43 and residues Asp-12 and
Arg-67 (forming a salt bridge upon ligand binding but not in
direct contact with the ligand) were mutated to alanines (Figs.
5A and 7A). Finally, a variant with a deletion of the large
B)-loop, which distinguishes PstA proteins from classical PII
proteins but is not expected to be involved in c-di-AMP bind-
ing, was constructed (variant "71–87 with deletion of amino
acids 71–87) (Fig. 7A). The His-PstASA protein and the differ-
ent His-PstASA variants K2A, D12A, T28A, N41A, T43A,
GGFL-AAAA, R67A, and "71–87 were overexpressed in
E. coli; whole cell lysates were prepared, and c-di-AMP binding
was assessed by DRaCALAs as described previously (Fig. 7, B
and C) (9). Reduced binding was seen for His-PstASA variants
T28A, N41A, and GGFL-AAAA, although the binding was not
markedly affected for variants K2A, D12A, T43A, R67A, and
"71–87 (Fig. 7,B andC). To confirm this, the different variants
FIGURE 5. PstASA-c-di-AMP complex structure. A, overlay of the apo-PstA (orange) and PstASA!c-di-AMP complex (yellow) monomer structures in schematic
representation. Amino acids Asp-12 and Arg-67 form a salt bridge in the complex structure and are shown as sticks;!-helices and"-sheets are numbered, and
T) and B)-loops are labeled. B, schematic representation of the c-di-AMP/PstASA trimerwith individualmonomers shown in different colors. C, close-up view of
apo-PstA (orange) and complex (yellow) secondary structure elements with Asp-12 and Arg-67 residues shown as sticks, and the corresponding 2Fo% Fcmap
contoured in blue at 1.0 root mean square deviation. For the Arg-67 residue in the apo structure, only density for the C" is present. D, simulated annealing
composite omit map at 1.0 root mean square deviation of the bound c-di-AMP in monomer A. E, close-up view of a c-di-AMP-binding site at the monomer-
monomer interface shown in surface potential representation.
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were purified and used in DRaCALAs (Fig. 8). The His6-
PstASA"71–87 protein precipitated during our standard puri-
fication process and could not be further analyzed. However,
the protein showed normal binding to c-di-AMP using whole
cell lysates, indicating that the large B)-loopwas not involved in
c-di-AMP binding. Identical c-di-AMP binding results were
obtained for the purified His-PstASA variants as with whole cell
lysates, with variants T28A, N41A, and GGFL-AAAA showing
a binding defect (Fig. 8B). Next, binding affinities were deter-
minedwith the purified proteins. Initial binding studies showed
that c-di-AMP bound to variants His-PstASA K2A, D12A, and
R67AwithKd values of 0.34* 0.04, 0.32* 0.05, and 0.48* 0.04
#M, which are similar to that of wild type His6-PstASA. A 5-fold
increase in the Kd value was observed for the T43A variant, to
which c-di-AMP bound with a Kd value of 1.8 * 0.2 #M as
compared with wild type His-PstASA with a Kd value of 0.37*
0.03 #M; however, the binding still reached saturation at a pro-
tein concentration above 20 #M (Fig. 8C). The protein variants
with the least binding capacity were the N41A variant with aKd
of 9.6 * 2.3 #M and the T28A and GGFL-AAAA variants, for
which no Kd values could be determined as the binding did not
reach saturation even at a protein concentration of 300 #M.
Therefore, in agreement with interactions seen in the co-com-
plex structure, conserved residues, Thr-28, Asn-41, and the
T)-loop residues GGFL are important for c-di-AMP binding.
Although other highly conserved residues, including residues
Asp-12 and Arg-67, which form a salt bridge in the ligand-
bound structure, are dispensable for c-di-AMP binding. These
data suggest that the physiologically relevant c-di-AMP-bind-
ing site was revealed in the complex structure.
DISCUSSION
Several c-di-AMP receptor proteins have now been identi-
fied (9–11, 43); however, so far only the structure of the L.
monocytogenes pyruvate carboxylase (PC) has been solved in
complex with c-di-AMP (11). Here, we present the structure of
the second target protein, namely the S. aureus PII-like signal
transduction protein PstA, in complex with c-di-AMP (Figs. 5
and 6). As discussed below, although the residues involved in
nucleotide binding are very distinct between these two proteins
(Fig. 9) and a classical consensus sequence cannot be estab-
lished, common features for c-di-AMP-binding sites can now
be proposed. In addition, a comparative analysis of the apo and
complex structures allows us to present a model on how this
protein functions as a signal transduction protein.
Although PstA is annotated as PII-like signal transduction
protein, our structural analysis together with a detailed bioin-
formatics analysis suggest that PstASA is a prototype of a new
protein family with clearly distinct features from classical PII
proteins. This new family of proteins currently contains around
900 members in the nonredundant protein database (Figs. 1A
and 3A). PstA homologs are present mainly in the Firmicutes,
with some homologs present in green non-sulfur bacteria,
Mycoplasmas, Spirochetes, and other unknown/unclassified
bacteria. This is consistent with the identification of predicted
c-di-AMP cyclases among most bacteria belonging to the
Firmicutes group. However, not all bacteria that can produce
c-di-AMP possess PstA homologs. Notably, a PstA homolog is
present in Bacillus subtilis 168 but absent in the pathogenic
strains Bacillus cereus, Bacillus anthracis, and B. thuringiensis.
Conversely, the thermophilic bacteria Sphaerobacter thermo-
philus DSM 20745 and Thermomicrobium roseum DSM 5159
encode three PstA orthologs, whereas the majority of other
bacteria contained only one PstA-type protein.
Comparison of the crystal structures of PII proteins and PstA
revealed that they share the same core fold. However, as shown
here, the twomain loops, named T- and B-loops in PII proteins
and T)- and B)-loops in PstA, are reversed in length and as we
would speculate also in function. In PII proteins, the B-loop is
short and contains the conserved Walker A motif sequence
FIGURE 6. c-di-AMP/PstASA hydrogenbondingnetwork.A, c-di-AMP-bind-
ing sitewith amino acid residues frommonomerA shown ingreen andmono-
mer B shown in yellow. Residue Phe-36 forms a face-to-face &-stacking with
adenine, and the other residues Leu-37, Asn-41 (monomer B), Thr-28, Gly-47,
and Gln-108 (monomer A) form hydrogen bonds with different parts of the
c-di-AMP ligand. Additional residues shown in the structure are Phe-99
(monomer B) and Arg-26 (monomer A), forming an edge-to-face &-stacking
and a cation-& interaction, respectively. Hydrogen bond interactions are
indicated with dotted lines and & interactions with double-head arrows. B,
schematic representation of the hydrogen bond interactions between
c-di-AMP-binding site residues. Residues from monomer A are shown in
green and from monomer B in yellow. The water molecules (indicated as
red W) forming hydrogen bonds are also shown in this schematic diagram.
The details of these interactions are described under “Results,” and ade-
nines are labeled A! and A", and PO4 groups 1 and 2, and will be referred
to as such in the text.
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TGXXGDGKI required for ADP or ATP binding, whereas in
PstA the short T)-loop contains the GGFL residues, which are
part of the highly conserved TKLXXXGGFLXXGNTT motif,
which is critical for c-di-AMP binding. The large T-loop in PII
proteins is involved in protein-protein interaction and changes
its conformation upon ligand binding. Two highly conserved
PII protein residues at the base of the large T-loop, Gln-39 and
Lys-58, interact with 2-OG when it is at a high cellular concen-
tration, and therefore bound to the protein, or forma salt bridge
when the cellular concentration is low and the protein is in an
unbound state. This results in a conformational change in the
T-loop allowing it to interact or disengage from its effector
protein, thus providing a structure-based mechanism for the
signal transduction properties of PII proteins in response to
2-OG levels. By obtaining the PstA apo- and c-di-AMP com-
plex structures, we can nowpropose a structure-basedmodel of
howPstA functions as a signal transduction protein. In the apo-
PstA structure both the T)- and B)-loops were unstructured,
indicating that they are highly flexible in the nucleotide-free
state (Fig. 3). Upon c-di-AMP binding, the T)-loop becomes
stabilized and structured through interactions with the nucle-
otide. The nucleotide-induced ordering of the T)-loop results
in small structural perturbations throughout the PstA trimer,
and in the complex structure a salt bridge between Asp-12 at
the end of !-helix 1 and Arg-67 at the beginning of the B)-loop
was observed (Fig. 5). In the apo structure, the side chain of
Arg-67 is not completely visible in the electron density maps
suggesting that it is highly flexible (Fig. 5C). We speculate that
the formation of the Asp-12–Arg-67 salt bridge could be asso-
ciated with the stabilization of the B)-loop, which forms two
anti-parallel "-strands that protrude from each monomer in
the trimer (Fig. 5B). However, further work is needed in the
future to experimentally test this hypothesis. As shown in this
study, neither residue Asp-12 nor Arg-67 is essential for c-di-
AMP binding (Figs. 7 and 8); however, both residues are highly
conserved within the PstA proteins indicating a functional
importance (Fig. 1). By analogy to PII proteins where residues
Gln-39 and Lys-58 stabilizes the conformation of the T-loop, it
can be speculated that residues Asp-12 andArg-67might play a
similar role in stabilizing the B)-loop in PstA proteins. Again,
similar to PII proteins, the conformational change in the large
B)-loop would presumably provide an interaction surface for
downstream effector proteins and in this manner affect their
activity. In the absence of c-di-AMP, such interactions would
be disengaged or prevented, thus establishing an elegant nucle-
otide-dependent signaling cascade. However, currently neither
the cellular function of the S. aureus PstA protein nor any other
PstA homologs are known nor have any interaction partner of
PstA proteins been identified. It is notable that the B)-loop dis-
plays large variations among PstA homologs (Fig. 1A), and this
might allow differentmembers of this protein family to interact
with diverse classes of effector proteins, similar to classical PII
proteins.
The apo-PstA structure was solved using the deposited P.
pentosaceus ATCC 25745 protein PEPE_1480 structure as a
model, which belongs to the same protein family. In the Pedio-
coccus structure, the T)-loop and a large part of B)-loop are
structured, whichwewould now refer to as being in the “ligand-
bound state.” This state was observed even though the protein
crystals were grown in the absence of c-di-AMP. However, the
FIGURE7.Locationofhighly conservedaminoacids inPstASAandtheir role inc-di-AMPbinding.A, schematic representationof thePstASAmonomer from
the complex structure in theConSurf representation (purple, high conservation;green,mediumconservation;white, lowconservation)with themutatedamino
acids shown in stick representation. Unstructured region of the B)-loops is schematically indicated. B, Coomassie-stained gel of whole cell extracts prepared
from E. coli BL21(DE3) strains containing the empty vector pET28b as negative control (NC), strains overproducingHis-PstASA (WT), or different protein variants
containing the amino acid substitutions as indicated above each lane. A protein marker was run alongside, and the molecular mass of the marker proteins is
indicated in kDa on the left and right sides of the panel. C, c-di-AMP binding assays. DRaCALAswere performedwith 32P-labeled c-di-AMP and the E. coliwhole
cell lysates described in B. Representative DRaCALA spots are shown, and the fraction bound was calculated as described previously, and the average values
and standard deviation of two independent experiments are plotted.
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crystallization buffer contained 0.2 M Li2SO4 and a closer
inspection of thePediococcus structure revealed the presence of
a sulfate molecule in a similar position to one of the phosphate
groups of the c-di-AMP ligand in the PstA!nucleotide complex.
Hydrogen bonds are formed between the sulfate group and
a conserved arginine residue (corresponding to Arg-26 in
PstASA) and the amide group of the highly conserved T)-loop
phenylalanine residue (Phe-36 in PstA). These interactions
could mimic the ligand-bound state by stabilizing the T)-loop.
The only other structure of a c-di-AMP bound protein com-
plex is that of the L. monocytogenes PC enzyme. This enzyme is
a tetramer composed of two layers of dimers with two nucle-
otide-binding sites (11). The c-di-AMP-binding sites are at
symmetrical monomer-monomer interfaces, with the same set
of amino acids from each monomer providing a half-binding
site, consistent with the 2-fold symmetric c-di-AMPnucleotide
(Fig. 9) (11). Specifically, a tyrosine residue fromeachmonomer
provides &-stacking interaction with the adenine rings, and
other tyrosine and serine residues form hydrogen bonds with
the terminal oxygen atomsof the phosphate groups (Fig. 9) (11).
The binding mode observed in the Listeria enzyme is similar
to the previously reported binding of c-di-GMP with the
eukaryotic immune receptor protein STING (44–46). How-
ever, no clear specificity determinants can be observed for pref-
erential interaction of the PC enzyme of L. monocytogeneswith
c-di-AMP versus other cyclic dinucleotides such as c-di-GMP.
As the PstA protein is trimeric (Figs. 2 and 5), this results in an
inherent asymmetry of the binding site with different amino
acids from eachmonomer contributing to ligand binding (Figs.
6 and 9). The bases of nucleotide ligands often form face-to-face
&-stacking interactionswith aromatic amino acids in the recep-
tor. In the c-di-AMP!PstA complex, however, only one of the
adenine bases (A!) forms a face-to-face &-stacking with Phe-
36, located within the highly conserved T)-loop, whereas the
second adenine (A") forms a face-to-edge stacking interaction
with Phe-99; both of these amino acids are on the same mono-
mer. In addition to the face-to-edge stacking interaction, the
second adenine base (A") forms additional hydrogen bond
interactions, including between its amino group and the amide
and carbonyl groups of Gly-47 (Figs. 6 and 9). The amino group
in the adenine base would be replaced with a carbonyl group in
a guanine base, and therefore such an interaction would be
energetically unfavorable. In addition, the amino group in a
guanine base would clash with the amide backbone of Leu-35,
thus providing a rationale for the specific binding of c-di-AMP
to PstA.
By comparing the PstA and PC ligand-bound structures, it is
apparent that c-di-AMP-binding sites are not conserved at the
amino acid sequence level; thus, establishing a universal
sequence motif for predicting c-di-AMP-binding sites in other
proteins may not be possible (Fig. 9). Despite this, a number of
conserved features of c-di-AMP-binding sites can now be iden-
tified, including a surface-accessible binding pocket formed
between two protomers, with an overall positive charge (as
observed for both PC and PstA), aromatic amino acids, such
as tyrosine or phenylalanine (at least one in asymmetric
binding sites and likely two in symmetric binding site), and
additional conserved amino acids, such as threonine, serine,
asparagine, or glutamine, which can provide for hydrogen
bond interactions with the phosphate and ribose groups.
Therefore, our study not only provides insight into how
members of the PstA protein family might function as signal
transduction proteins, but also highlights conserved features
of c-di-AMP-binding sites that will aid future studies and
FIGURE 8. Identification of PstA variants with c-di-AMP-binding defects.
A, Coomassie-stained gel with purified His-PstASA protein (WT) and different
protein variants containing the amino acid substitutions as indicated above
each lane. B, c-di-AMP binding assays. DRaCALAs were performed with 32P-
labeled c-di-AMP and purified His-PstASA protein (WT) or variants with the
indicated amino acid substitution. The proteins were used at a concentration
of 10 #M, and as negative control (NC) no protein was added to the binding
assays. Representative DRaCALA spots are shown, and the fraction bound
was calculated as described previously, and the average values and standard
deviation of two independent experiments were plotted. C, binding curve
and Kddetermination for c-di-AMP andpurifiedHis-PstASA or protein variants
with the indicated amino acid substitutions. Kd values were determined from
the curve as described previously (41).
FIGURE 9. Comparison of S. aureus PstA and L. monocytogenes PC c-di-
AMP-binding sites. A and B, schematic representations of c-di-AMP-binding
site in S. aureus PstASA (A) and L. monocytogenes PC (PDB 4QSH) (11) (B) with
different monomers shown in green and yellow, respectively. Amino acid res-
idues forming key contact with the ligand are labeled and shown as sticks.
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allow for amore rational approach for identifying c-di-AMP-
binding sites within target proteins.
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